Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

Creative Commons License

Bastidas A., de la Serna J., El Idrissi M., Oostvogels L., Quittet P., Lopez-Jimenez J., ...More

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, vol.322, no.2, pp.123-133, 2019 (SCI-Expanded) identifier identifier identifier


IMPORTANCE Herpes zoster, a frequent complication following autologous hematopoietic stem cell transplantation (HSCT), is associated with significant morbidity. A nonlive adjuvanted recombinant zoster vaccine has been developed to prevent posttransplantation zoster.